These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7980588)

  • 1. Binding and cAMP studies of melanotropin peptides with the cloned human peripheral melanocortin receptor, hMC1R.
    Haskell-Luevano C; Miwa H; Dickinson C; Hruby VJ; Yamada T; Gantz I
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1137-42. PubMed ID: 7980588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
    Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
    J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
    Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
    J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizations of the unusual dissociation properties of melanotropin peptides from the melanocortin receptor, hMC1R.
    Haskell-Luevano C; Miwa H; Dickinson C; Hadley ME; Hruby VJ; Yamada T; Gantz I
    J Med Chem; 1996 Jan; 39(2):432-5. PubMed ID: 8558511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists.
    Haskell-Luevano C; Sawyer TK; Trumpp-Kallmeyer S; Bikker JA; Humblet C; Gantz I; Hruby VJ
    Drug Des Discov; 1996 Dec; 14(3):197-211. PubMed ID: 9017363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
    Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
    J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topographical modification of melanotropin peptide analogues with beta-methyltryptophan isomers at position 9 leads to differential potencies and prolonged biological activities.
    Haskell-Luevano C; Boteju LW; Miwa H; Dickinson C; Gantz I; Yamada T; Hadley ME; Hruby VJ
    J Med Chem; 1995 Nov; 38(23):4720-9. PubMed ID: 7473600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning, functional expression and pharmacological characterization of a mouse melanocortin receptor gene.
    Desarnaud F; Labbe O; Eggerickx D; Vassart G; Parmentier M
    Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):367-73. PubMed ID: 8172596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat.
    Adan RA; Szklarczyk AW; Oosterom J; Brakkee JH; Nijenhuis WA; Schaaper WM; Meloen RH; Gispen WH
    Eur J Pharmacol; 1999 Aug; 378(3):249-58. PubMed ID: 10493100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of the melanocortin 4 receptor by radioligand binding.
    Schiöth HB; Muceniece R; Wikberg JE
    Pharmacol Toxicol; 1996 Sep; 79(3):161-5. PubMed ID: 8884876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis.
    Suzuki I; Cone RD; Im S; Nordlund J; Abdel-Malek ZA
    Endocrinology; 1996 May; 137(5):1627-33. PubMed ID: 8612494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics.
    Al-Obeidi F; Castrucci AM; Hadley ME; Hruby VJ
    J Med Chem; 1989 Dec; 32(12):2555-61. PubMed ID: 2555512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformation of the core sequence in melanocortin peptides directs selectivity for the melanocortin MC3 and MC4 receptors.
    Oosterom J; Nijenhuis WA; Schaaper WM; Slootstra J; Meloen RH; Gispen WH; Burbach JP; Adan RA
    J Biol Chem; 1999 Jun; 274(24):16853-60. PubMed ID: 10358030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for the interaction of [Nle4,D-Phe7]melanocyte stimulating hormone with the human melanocortin-1 receptor.
    Yang Yk; Dickinson C; Haskell-Luevano C; Gantz I
    J Biol Chem; 1997 Sep; 272(37):23000-10. PubMed ID: 9287296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I beta-turn conformation is important for biological activity of the melanocyte-stimulating hormone analogues.
    Li SZ; Lee JH; Lee W; Yoon CJ; Baik JH; Lim SK
    Eur J Biochem; 1999 Oct; 265(1):430-40. PubMed ID: 10491201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues.
    Labbé O; Desarnaud F; Eggerickx D; Vassart G; Parmentier M
    Biochemistry; 1994 Apr; 33(15):4543-9. PubMed ID: 8161509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further pharmacological characterization of the selective melanocortin 4 receptor antagonist HS014: comparison with SHU9119.
    Schiöth HB; Muceniece R; Mutulis F; Bouifrouri AA; Mutule I; Wikberg JE
    Neuropeptides; 1999 Jun; 33(3):191-6. PubMed ID: 10657491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding and biological activity of C-terminally modified melanocortin peptides: a comparison between their actions at rodent MC1 and MC3 receptors.
    Peng PJ; Sahm UG; Doherty RV; Kinsman RG; Moss SH; Pouton CW
    Peptides; 1997; 18(7):1001-8. PubMed ID: 9357058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent and selective agonists of human melanocortin receptor 5: cyclic analogues of alpha-melanocyte-stimulating hormone.
    Bednarek MA; MacNeil T; Tang R; Fong TM; Cabello MA; Maroto M; Teran A
    J Med Chem; 2007 May; 50(10):2520-6. PubMed ID: 17455928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.